Discover 2,423 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,423
Active & Responsive
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
for
Peanut Allergy
Location: Baltimore MD, New York NY, Chapel Hill NC, Boston MA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 12 - 55
Code: NCT07015996
Phase 2, Recruiting
Active & Responsive
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: Baltimore MD, New York NY, Chapel Hill NC, Ann Arbor MI,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & Responsive
Feasibility Study for Fibroblast Autologous Skin Grafts
for
Wounds and Injuries
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 65
Code: NCT01964859
Phase 2, Recruiting
Active & Responsive
Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
for
Billiary Track Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT06001658
Phase 2, Recruiting
Active & Responsive
DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 12+
Code: NCT04248569
Phase 1, Recruiting
Active & Responsive
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
for
Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 12+
Code: NCT07430202
Phase 1, Recruiting
Active & Responsive
Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18 - 70+
Code: NCT07424222
Phase 1, Recruiting
Active & Responsive
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
for
Colorectal Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT07281768
Phase 2, Recruiting
Active & Responsive
Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia